Can State Votes Really Cut Your Pharmacy Bill? | Simplefill

Yes — state legislation can meaningfully reduce prescription drug costs, and recent state and federal actions in 2025 and 2026 are already delivering real savings for millions of Americans. But how much states can do has real limits, which is why knowing all your options matters just as much as following the latest legislative news.

What Power Do States Actually Have Over Drug Prices?

States hold more sway over your pharmacy bill than most people realize. As of April 2025, approximately 23 states had passed drug price transparency laws, and 12 states had established Prescription Drug Affordability Boards (PDABs) — regulatory bodies with authority to review the cost of specific medications and set upper payment limits on what residents pay. States like Minnesota, Colorado, and Maryland are actively using these boards to prevent runaway price hikes on high-cost medications.​

States can also pass bills that regulate pharmacy benefit managers (PBMs) — the powerful middlemen who negotiate drug prices between manufacturers and insurers. More than 30 states introduced legislation in recent years to counteract restrictions on the federal 340B Drug Pricing Program, with eight states successfully passing laws that expand access to deeply discounted drugs for underserved populations.​

What State-Level Laws Are Making a Real Difference Right Now?

Are PBM Reforms Actually Working?

PBMs have long been criticized for driving up costs by favoring high-priced drugs that generate larger rebates for themselves. States are fighting back. Arkansas passed House Bill 1150 — the first state law in the country to ban PBM ownership of pharmacies, targeting a significant conflict of interest — though its enforcement is currently paused due to a legal challenge. This highlights an important reality: can a state drug pricing bill be overturned? Yes. State laws can face federal preemption arguments or industry lawsuits that delay or block enforcement. But even when litigation slows progress, these laws shift the policy landscape and create pressure for broader reform.​

What Are Prescription Drug Affordability Boards Doing?

Nine states now have PDABs actively reviewing drug costs. Minnesota recently expanded its PDAB authority to set upper payment limits on high-cost drugs, and it is using prices negotiated under the federal Inflation Reduction Act as a benchmark ceiling. These boards give states a structural tool to directly cap what residents pay — a significant power that didn’t exist just a decade ago.

Do Drug Price Transparency Laws Actually Help Patients?

Twenty-three states now require drug manufacturers, PBMs, or insurers to publicly report pricing data, making it much harder for the industry to raise prices quietly. Transparency requirements create public accountability and feed critical data into affordability reviews — and they’ve already helped expose price hikes that previously went unnoticed.​

What Does Federal Action Add to the Picture?

Federal legislation has added serious momentum. In February 2026, Congress enacted the Consolidated Appropriations Act, 2026 (H.R. 7148), bringing sweeping PBM reform at the national level. Starting in 2028, PBMs in Medicare Part D will be compensated only through flat, fixed service fees — not through percentages of a drug’s list price. This directly removes the financial incentive to steer patients toward expensive drugs over affordable alternatives. The law also requires PBMs to pass 100% of rebates to employer health plans, which should reduce out-of-pocket costs for covered workers.

Separately, the first set of Medicare-negotiated drug prices under the Inflation Reduction Act took effect in 2026, covering 10 high-cost medications at prices that are a minimum of 38% below their 2023 list prices. These negotiations are estimated to save Medicare beneficiaries $1.5 billion annually in out-of-pocket costs. In 2027, 15 more drugs — including Ozempic and other blockbuster diabetes medications — will be added to the negotiated pricing list.​

What Happens When a Drug Pricing Bill Stalls in Congress?

It’s a frustrating but important reality. When a bill stalls in Congress and doesn’t get voted through, it dies. Legislation that fails to pass before the end of a congressional session expires and must be reintroduced from scratch in the next session. The Prescription Drug Price Relief Act of 2025, for example, was introduced to aggressively benchmark U.S. drug prices against international rates but had not passed as of early 2026. When federal bills stall or fail, states often step in — which is exactly the pattern we’ve seen with the surge in state PBM and affordability laws over the past two years.

It’s also worth clarifying the boundaries of state power. States cannot recall a sitting U.S. congressman — federal recall of members of Congress is not permitted under the Constitution. States also have very limited authority over federal electoral processes once set in motion. State drug pricing power, while meaningful and growing, always operates within the boundaries of federal law.

How Do These Changes Affect You Right Now?

For most Americans — especially those without insurance or with high deductibles — the practical impact of new legislation is still catching up with what patients face at the pharmacy counter today. With over 350 brand-name drugs seeing price hikes in 2026, the financial burden hasn’t disappeared despite policy progress. PBM compensation reforms won’t fully take effect until 2028. PDAB upper payment limits are still being developed in most states. And Medicare drug negotiations benefit Medicare enrollees specifically — they don’t automatically lower prices for the uninsured or privately insured.

If you’re struggling to afford your medications today, waiting for the next legislative session is not a plan. That’s where prescription assistance programs become essential.

How Can Simplefill Help When Laws Fall Short?

Simplefill’s patient assistance program connects uninsured and underinsured Americans with pharmaceutical company programs, state-sponsored initiatives, and other funding sources that can provide brand-name and specialty drugs at little to no cost — completely independent of whatever is happening in any state legislature.

For additional tools you can use right now alongside any policy changes, explore 10 ways to lower your prescription costs — a practical guide to maximizing every available savings option no matter your insurance status.

Get Affordable Access to Prescription Medications

Simplefill is a full-service prescription assistance company that maintains patients’ enrollment in all sources of assistance available to them.

Apply today by calling 877-386-0206. A representative will contact you within 24 hours.

Frequently Asked Questions

Can states really lower drug prices on their own?

Yes. States can regulate PBMs, establish drug affordability boards with power to set upper payment limits, pass price transparency laws, and expand access to 340B discounted drug pricing — all without waiting for federal action.

What happens when a drug pricing bill doesn’t pass in Congress?

It expires at the end of the congressional session and must be reintroduced. States often fill the gap with their own legislation, which is why state-level PBM and affordability laws have surged in recent years.​

Can a state drug pricing law be overturned or blocked?

Yes. State laws can be challenged in court on federal preemption grounds, or blocked by industry litigation. Arkansas’s PBM pharmacy ownership ban is a recent example — it passed but is currently under a legal enforcement pause.​

Do the 2026 Medicare drug price negotiations help me if I’m not on Medicare?

The negotiated prices apply specifically to Medicare Part D and Part B enrollees. However, some states — like Minnesota — are already using these prices as reference benchmarks for their own upper payment limits, which could eventually broaden the impact.

How does Simplefill differ from a discount card like GoodRx?

Simplefill goes beyond coupons by enrolling you in pharmaceutical patient assistance programs that can provide medications free or at near-zero cost. Simplefill also monitors your refills, manages renewals, and advocates for you continuously — ongoing support that a discount card simply doesn’t offer.​

What if my state hasn’t passed any drug pricing legislation?

You still have options. Federal PBM reforms, Medicare drug negotiations, and manufacturer patient assistance programs are available to eligible patients nationwide. Simplefill can identify and enroll you in every program you qualify for, regardless of your state